PPD Stock Forecast, Price & News

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PPD in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PPD stock.
View analyst ratings for PPD or view top-rated stocks.

Wall Street analysts have given PPD a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PPD wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

PPD saw a increase in short interest in February. As of February 12th, there was short interest totaling 4,280,000 shares, an increase of 28.1% from the January 28th total of 3,340,000 shares. Based on an average daily trading volume, of 970,600 shares, the short-interest ratio is presently 4.4 days. Approximately 3.7% of the shares of the company are sold short.
View PPD's Short Interest.

PPD is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for PPD.

PPD, Inc. (NASDAQ:PPD) posted its earnings results on Wednesday, February, 24th. The company reported $0.39 EPS for the quarter, topping the Zacks' consensus estimate of $0.36 by $0.03. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.28 billion. PPD had a negative trailing twelve-month return on equity of 11.06% and a net margin of 0.21%. The business's revenue for the quarter was up 30.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 EPS.
View PPD's earnings history.

PPD's stock was trading at $25.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PPD stock has increased by 34.9% and is now trading at $34.76.
View which stocks have been most impacted by COVID-19.

PPD issued an update on its FY21 earnings guidance on Tuesday, February, 23rd. The company provided earnings per share (EPS) guidance of $1.37-1.45 for the period, compared to the Thomson Reuters consensus estimate of $1.39. The company issued revenue guidance of $5.145-5.304 billion, compared to the consensus revenue estimate of $5.07 billion.

11 Wall Street analysts have issued 12-month target prices for PPD's stock. Their forecasts range from $20.00 to $42.00. On average, they anticipate PPD's stock price to reach $36.82 in the next year. This suggests a possible upside of 5.9% from the stock's current price.
View analysts' price targets for PPD or view top-rated stocks among Wall Street analysts.

Some companies that are related to PPD include IQVIA (IQV), Bitcoin Group (BTGGF), Exact Sciences (EXAS), Incyte (INCY), Charles River Laboratories International (CRL), ICON Public (ICLR), PRA Health Sciences (PRAH), Syneos Health (SYNH), Exelixis (EXEL), Medpace (MEDP), Precigen (PGEN), National Research (NRC), Anavex Life Sciences (AVXL), Starpharma (SPHRY) and Luna Innovations (LUNA).
View all of PPD's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), salesforce.com (CRM), Pfizer (PFE), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Raytheon Technologies (RTX) and Verizon Communications (VZ).

(PPD) raised $1.5 billion in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 60,000,000 shares at $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers.

PPD trades on the NASDAQ under the ticker symbol "PPD."

PPD's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (3.83%), Price T Rowe Associates Inc. MD (3.73%), UBS Asset Management Americas Inc. (2.16%), D1 Capital Partners L.P. (0.86%), Boston Partners (0.84%) and Boston Partners (0.84%). Company insiders that own PPD stock include Carlyle Group Management LLC, Christopher Fikry, Colin Hill, David Michael Johnston, David S Simmons, Glen Donovan, Jill Pellegrino, Karen Kaucic, Ronald E Garrow and William J Sharbaugh.
View institutional ownership trends for PPD.

PPD stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Alyeska Investment Group L.P., D1 Capital Partners L.P., Clearbridge Investments LLC, Pura Vida Investments LLC, Brookfield Asset Management Inc., Renaissance Technologies LLC, and Laurion Capital Management LP. Company insiders that have sold PPD company stock in the last year include Carlyle Group Management LLC, Colin Hill, David Michael Johnston, David S Simmons, Glen Donovan, Jill Pellegrino, Karen Kaucic, and Ronald E Garrow.
View insider buying and selling activity for PPD or view top insider-selling stocks.

PPD stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, BlackRock Inc., Price T Rowe Associates Inc. MD, UBS Asset Management Americas Inc., Swiss National Bank, Jennison Associates LLC, Sumitomo Mitsui Trust Holdings Inc., and Nuveen Asset Management LLC. Company insiders that have bought PPD stock in the last two years include Christopher Fikry, David S Simmons, and William J Sharbaugh.
View insider buying and selling activity for PPD or or view top insider-buying stocks.

Shares of PPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PPD stock can currently be purchased for approximately $34.76.

PPD has a market capitalization of $12.18 billion and generates $4.03 billion in revenue each year. The company earns $47.82 million in net income (profit) each year or $0.98 on an earnings per share basis.

PPD employs 25,000 workers across the globe.

The official website for PPD is www.ppdi.com.

PPD is headquartered at 929 NORTH FRONT STREET, WILMINGTON NC, 28401.

PPD's mailing address is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. The company can be reached via phone at 910-251-0081 or via email at [email protected]